| Title |
The utility of urine-circulating miRNAs for detection of prostate cancer |
| Authors |
Stuopelytė, Kristina ; Daniūnaitė, Kristina ; Bakavičius, Arnas ; Lazutka, Juozas Rimantas ; Jankevičius, Feliksas ; Jarmalaitė, Sonata |
| DOI |
10.1038/bjc.2016.233 |
| Full Text |
|
| Is Part of |
British journal of cancer.. London : Nature Publishing Group. 2016, Vol. 115, no 6, p. 707-715.. ISSN 0007-0920. eISSN 1532-1827 |
| Keywords [eng] |
prostate cancer ; miRNA ; urine ; miR-148a ; miR-375 |
| Abstract [eng] |
Background: In this paper, the utility of urine-circulating microRNAs (miRNAs) as the potential biomarker of prostate cancer (PCa), the second most prevalent male cancer worldwide, was evaluated. Methods: Cancerous (N=56) and non-cancerous (N=16) prostate tissues were analysed on TaqMan Low Density Array, with the initial screening of 754 miRNAs in a subset of the samples. The abundance of selected miRNAs was analysed in urine specimens from two independent cohorts of patients with PCa (N=215 overall), benign prostatic hyperplasia (BPH; N=23), and asymptomatic controls (ASC; N=62) by means of quantitative reverse transcription PCR. Results: Over 100 miRNAs were found deregulated in PCa as compared with non-cancerous prostate tissue. After thorough validation, four miRNAs were selected for the analysis in urine specimens. The abundance of miR-148a and miR-375 in urine was identified as specific biomarkers of PCa in both cohorts. Combined analysis of urine-circulating miR-148a and miR-375 was highly sensitive and specific for PCa in both cohorts (AUC=0.79 and 0.84) and strongly improved the diagnostic power of the PSA test (AUC=0.85, cohort PCa1), including the grey diagnostic zone (AUC=0.90). Conclusions: Quantitative measurement of urine-circulating miR-148a and miR-375 can serve as the non-invasive tool for sensitive and specific detection of PCa. |
| Published |
London : Nature Publishing Group |
| Type |
Journal article |
| Language |
English |
| Publication date |
2016 |
| CC license |
|
